Drug Profile
Sarconeos - Biophytis
Alternative Names: 20-hydroxyecdysone - Biophytis; BIO 101Latest Information Update: 12 Apr 2024
Price :
$50
*
At a glance
- Originator Biophytis
- Class Cyclopentanes; Ketones; Obesity therapies; Phenanthrenes; Small molecules
- Mechanism of Action Proto-oncogene protein c-mas-1 agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase III SARS-CoV-2 acute respiratory disease
- Phase II Sarcopenia
- Phase I Duchenne muscular dystrophy
- No development reported Obesity